Researchers track where Radium-223 goes in bones of prostate cancer patients
NCT ID NCT04521361
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 30 times
Summary
This study looked at how the drug radium-223 moves through bones in men whose prostate cancer has spread to the bone. About 60 men with at least 18 years of age took part, split into two groups based on how many bone tumors they had. They received up to 6 injections of radium-223, and scans were used to see where the drug went. The goal was to learn more about the drug's distribution, not to treat the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Azienda USL IRCCS di Reggio Emilia_Arcispedale Santa Maria Nuova - S.C. Oncologia Provinciale
Reggio Emilia, Emilia-Romagna, 42123, Italy
-
Guy's and St. Thomas' NHS Trust, St. Thomas' Hospital
London, SE1 7EH, United Kingdom
-
HCL - Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
ICM - Institut du Cancer de Montpellier - Val d'Aurelle
Montpellier, 34298, France
-
Institut Claudius Regaud - iUCT Oncopole
Toulouse, 31059, France
-
Institut de Cancerologie Ouest - Saint-Herblain
Saint-Herblain, 44800, France
-
National Cancer Institute
Vilnius, LT-08660, Lithuania
-
Rambam Health Corporation
Haifa, 3109601, Israel
-
Royal Marsden NHS Trust (Surrey)
Sutton, Surrey, SM2 5PT, United Kingdom
-
Uniklinikum Salzburg - Landeskrankenhaus
Salzburg, 5020, Austria
-
University College London Hospitals NHS Foundation Trust
London, NW1 2PG, United Kingdom
-
Vilnius University Hospital Santaros Klinikos
Vilnius, LT-08661, Lithuania
Conditions
Explore the condition pages connected to this study.